Hypocellular Myelodysplastic Syndrome

Myelodysplastic syndrome characterized by decreased cellularity in the bone marrow.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Primary myelodysplastic syndrome (MDS) with myelofibrosis is a rare hematological disorder that should be classified as a… (More)
  • figure 1
  • figure 2
Is this relevant?
2014
2014
The distinction between acquired aplastic anemia (AA) and hypocellular myelodysplastic syndrome (hMDS) is often difficult… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
2014
2014
BACKGROUND The presence of significant dysplasia in bone marrow (BM) aspirates helps to distinguish between hypocellular… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2012
2012
BACKGROUND Although most patients with myelodysplastic syndrome (MDS) exhibit bone marrow hypercellularity, a subset of them… (More)
Is this relevant?
2012
2012
This report describes the final results of a Phase II clinical trial investigating the efficacy of rabbit antithymocyte globulin… (More)
Is this relevant?
2008
2008
Hypocellular myelodysplastic syndrome (MDS) represents only a small portion of MDS, of which, the clinical significance has not… (More)
Is this relevant?
2007
2007
A 16-year-old female patient presented with complaints of malaise, dizziness, syncope, and nausea of 1-week duration. On… (More)
Is this relevant?
2000
2000
Non-caseating granuloma (NCG) remains a histopathological hallmark for sarcoidosis. Although the exact mechanism for NCG… (More)
Is this relevant?
1995
1995
It is important to differentiate non-dyplastic aplastic anaemia from hypocellular myelodysplastic syndrome (MDS). Four patients… (More)
Is this relevant?
1985
1985
In a retrospective study of 111 patients with aplastic anaemia iliac crest biopsies were evaluated for the presence of… (More)
Is this relevant?